Novel non-invasive adjunctive techniques for early oral cancer diagnosis and oral lesions examination

Current Pharmaceutical Design

Volumn 18, Issue 34, 2012, Pages 5442-5451

  Mercadante, Valeria ^a   Paderni, Carlo ^b   Campisi, Giuseppina ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Autofluorescence; Chemiluminescence; Early diagnosis; Exfoliative cytology; Narrow band imaging; Oral biopsy; Oral cancer; Potentially malignant disorder; Screening; Vital staining

Indexed keywords

TOLONIUM CHLORIDE;

AUTOFLUORESCENCE; CANCER DIAGNOSIS; CHEMOLUMINESCENCE; CHROMOENDOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EXFOLIATIVE CYTOLOGY; FALSE NEGATIVE RESULT; LEUKOPLAKIA; MOUTH CANCER; NARROW BAND IMAGING; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; REVIEW;

EARLY DETECTION OF CANCER; HUMANS; LUMINESCENT MEASUREMENTS; MASS SCREENING; MOUTH NEOPLASMS; NARROW BAND IMAGING; OPTICAL IMAGING; PRECANCEROUS CONDITIONS; STAINING AND LABELING;

EID: 84867723796     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803307626     Document Type: Review

References (107)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 2009; 45(4-5): 309-16.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca-A Cancer Journal for Clinicians 2005; 55(2): 74-108.
3. Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head and Neck 2007; 29(8): 779-92.
4. Scott S, McGurk M, Grunfeld E. Patient delay for potentially malignant oral symptoms. European Journal of Oral Sciences 2008; 116(2): 141-7.
5. Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncology 2009; 45(3): 201-11.
6. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 2007; 12(1): 20-37.
7. Warnakulasuriya S, Johnson NW, Van Der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of Oral Pathology and Medicine 2007; 36(10): 575-80.
8. Böcking A, Sproll C, Stöcklein N, et al. Role of brush biopsy and DNA cytometry for prevention, diagnosis, therapy, and followup care of oral cancer. Journal of Oncology 2011.
9. Saadeh CE. Chemotherapyand radiotherapy-induced oral mucositis: review of preventive strategies and treatment. Pharmacotherapy 2005; 25(4): 540-54.
10. Mignogna MD, Fedele S. Oral cancer screening: 5 Minutes to save a life. Lancet 2005; 365(9475): 1905-6.
11. Patton LL. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncology 2003; 39(7): 708-23.
12. Neville BW, Day TA. Oral cancer and precancerous lesions. Ca-A Cancer Journal for Clinicians 2002; 52(4): 195-215.
13. Das BR, Nagpal JK. Understanding the biology of oral cancer. Medical Science Monitor 2002; 8(11): RA258-RA67.
14. Shugars DC, Patton LL. Detecting, diagnosing, and preventing oral cancer. The Nurse practitioner 1997; 22(6): 105, 9-10, 13-15 passim.
15. Thomson PJ. Field change and oral cancer: New evidence for widespread carcinogenesis? International J Oral Maxillofacial Surgery 2002; 31(3): 262-6.
16. Lee JJ, Hung HC, Cheng SJ, et al. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2007; 104(2): 217-25.
17. Seoane J, Varela-Centelles PI, Ramirez JR, Cameselle-Teijeiro J, Romero MA. Artefacts in oral incisional biopsies in general dental practice: a pathology audit. Oral Dis 2004; 10(2): 113-7.
18. Seoane J, Varela-Centelles P, Ramirez JR, Romero MA, De La Cruz A. Artefacts produced by suture traction during incisional biopsy of oral lesions. Clinical Otolaryngology and Allied Sciences 2002; 27(6): 549-53.
19. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis a systematic review of the literature. Journal of the American Dental Association 2008; 139(7): 896-905.
20. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and 1995; 80(2): 188-91.
21. Fischer DJ, Epstein JB, Morton Jr TH, Schwartz SM. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncology 2005; 41(5): 489-96.
22. Du GF, Li CZ, Chen HZ, et al. Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: A pilot study. International Journal of Cancer 2007; 120(9): 1958-63.
23. Chen HZ. Rose bengal staining for clinical detection of oral premalignant lesions and carcinomas. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology 1992; 27(1): 44-7.
24. Chen YW, Lin JS, Fong JHJ, et al. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. British Journal of Oral and Maxillofacial Surgery 2007; 45(7): 590-1.
25. Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y. Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral squamous cell carcinoma and precancer lesions. Journal of the Chinese Medical Association 2007; 70(11): 497-503.
26. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. Journal of Oral Pathology and Medicine 1992; 21(4): 160-3.
27. Kurita H, Kamata T, Li X, Nakanishi Y, Shimane T, Koike T. Effectiveness of vital staining with iodine solution in reducing local recurrence after resection of dysplastic or malignant oral mucosa. Br J Oral Maxillofacial Surgery 2012; 50(2): 109-12.
28. Petruzzi M, Lucchese A, Baldoni E, Grassi FR, Serpico R. Use of Lugol's iodine in oral cancer diagnosis: An overview. Oral Oncology 2010; 46(11): 811-3.
29. Epstein JB, Guneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg 2009; 17(2): 79-87.
30. Epstein JB, Oakley C, Millner A, Emerton S, Van Der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontics 1997; 83(5): 537-47.
31. Missmann M, Jank S, Laimer K, Gassner R. A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiol Endodontol 2006; 102(6): 741-3.
32. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontics 2003; 95(1): 45-50.
33. Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005; 65(17): 8017-21.
34. Epstein JB, Feldman R, Dolor RJ, Porter SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head and Neck 2003; 25(11): 911-21.
35. Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra WH, Koch WM, Sidransky D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clinical Cancer Research 2001; 7(7): 1963-8.
36. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncology 2008; 44(1): 10-22.
37. Gupta A, Singh M, Ibrahim R, Mehrotra R. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions. Acta Cytologica 2007; 51(5): 788-94.
38. Epstein JB, Güneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Current Opinion in Otolaryngology and Head and Neck Surgery 2009; 17(2): 79-87.
39. Lonky NM, Edwards G. Comparison of chemiluminescent light versus incandescent light in the visualization of acetowhite epithelium. Am J Gynecol Health 1992; 6(1): 11-5.
40. Suneja A, Mahishee, Agarwal N, Misra K. Comparision of magnified chemiluminescent examination with incandescent light examination and colposcopy for detection of cervical neoplasia. Indian J Cancer 1998; 35(2): 81-7.
41. Wertlake PT, Francus K, Newkirk GR, Parham GP. Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: A community-based clinical trial. Obstetrics Gynecol 1997; 90(3): 421-7.
42. Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: A pilot study. Quintessence International 2004; 35(5): 378-84.
43. Nair DR, Pruthy R, Pawar U, Chaturvedi P. Oral cancer: Premalignant conditions and screening - An update. J Cancer Res Therapeut 2012; 8(SUPPL. 2): S57-S66.
44. Fedele S. Diagnostic aids in the screening of oral cancer. Head neck Oncol 2009; 1: 5.
45. Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, Cano-Sánchez J, Bascones-Martínez A. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Medicina Oral, Patologia Oraly Cirugia Bucal 2009; 14(5): E210-E6.
46. Oh ES, Laskin DM. Efficacy of the ViziLite System in the Identification of Oral Lesions. Journal of Oral and Maxillofacial Surgery 2007; 65(3): 424-6.
47. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. International Journal of Oral and Maxillofacial Surgery 2005; 34(5): 521-7.
48. Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite'™) in the visualisation of oral mucosal white lesions. Oral Oncology 2007; 43(8): 820-4.
49. Epstein JB, Silverman Jr S, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncology 2008; 44(6): 538-44.
50. Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med 2011; 40(7): 541-4.
51. Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: Avenues to early detection. Head Neck Oncol 2011; 3(1).
52. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope'®) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 2011; 47(4): 274-7.
53. McIntosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/DL™) in the visualisation of oral mucosal lesions. Oral Oncol 2009; 45(12): e227-e31.
54. Alaa Rm M, Shibuya K, Fujiwara T, et al. Risk of lung cancer in patients with preinvasive bronchial lesions followed by autofluorescence bronchoscopy and chest computed tomography. Lung Cancer 2010 Oct 30.
55. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 2005; 41(2): 117-31.
56. Lane PM, Gilhuly T, Whitehead P, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006; 11(2): 024006.
57. Ramanujam N, Mitchell MF, Mahadevan A, et al. Spectroscopic diagnosis of cervical intraepithelial neoplasia (CIN) in vivo using laser-induced fluorescence spectra at multiple excitation wavelengths. Lasers Surg Med 1996; 19(1): 63-74.
58. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res 2008; 14(8): 2396-404.
59. Ramanujam N. Fluorescence spectroscopy of neoplastic and nonneoplastic tissues. Neoplasia 2000; 2(1-2): 89-117.
60. Jayaprakash V, Sullivan M, Merzianu M, et al. Autofluorescenceguided surveillance for oral cancer. Cancer Prev Res (Phila) 2009; 2(11): 966-74.
61. Roblyer D, Kurachi C, Stepanek V, et al. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila) 2009; 2(5): 423-31.
62. Balevi B. Evidence-based decision making: should the general dentist adopt the use of the VELscope for routine screening for oral cancer? J Can Dent Assoc 2007; 73(7): 603-6.
63. Trullenque-Eriksson A, Munoz-Corcuera M, Campo-Trapero J, Cano-Sanchez J, Bascones-Martinez A. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal 2009; 14(5): E210-6.
64. Ingber DE. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 2002; 70(9-10): 547-60.
65. Arifler D, Pavlova I, Gillenwater A, Richards-Kortum R. Light scattering from collagen fiber networks: Micro-optical properties of normal and neoplastic stroma. Biophysical Journal 2007; 92(9): 3260-74.
66. Lane PM, Gilhuly T, Whitehead P, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. Journal of Biomedical Optics 2006; 11(2).
67. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncology 2011; 47(4): 274-7.
68. Kois JC, Truelove E. Detecting oral cancer: A new technique and case reports. Dentistry Today 2006; 25(10): 94-7.
69. Westra WH, Sidransky D. Fluorescence visualization in oral neoplasia: Shedding light on an old problem. Clinical Cancer Research 2006; 12(22): 6594-7.
70. Moles DR, Downer MC, Speight PM. Meta-analysis of measures of performance reported in oral cancer and precancer screening studies. British Dental J 2002; 192(6): 340-4.
71. Poh CF, Zhang L, Anderson DW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clinical Cancer Res 2006; 12(22): 6716-22.
72. Poh CF, Ng SP, Williams PM, et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head and Neck 2007; 29(1): 71-6.
73. Mehrotra R, Singh M, Thomas S, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dental Association 2010; 141(2): 151-6.
74. Ben BB. Evidence-based decision making: should the general dentist adopt the use of the VELscope for routine screening for oral cancer? CORD Conference Proceedings 2007; 73(7): 603-6.
75. Poh CF, Zhang L, Anderson DW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006; 12(22): 6716-22.
76. Wang YC, Fang KH, Jung SM, Zheng J, Hao SP. Excisional biopsy with margin control for oral cancers. Head Neck 2010; 32(11): 1528-33.
77. Gauthier P, Audet N, Guertin L, et al. Complete frozen section margins (with measurable 1 or 5 mm thick free margin) for cancer of the tongue: part 2: clinical experience. J Otolaryngol Head Neck Surg 2010; 39(1): 20-7.
78. Balevi B. Assessing the usefulness of three adjunctive diagnostic devices for oral cancer screening: A probabilistic approach. Community Dentistry and Oral Epidemiology 2011; 39(2): 171-6.
79. López-Jornet P, De la Mano-Espinosa T. The efficacy of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice: an update. International journal of dental hygiene 2011; 9(2): 97-100.
80. Paderni C, Compilato D, Carinci F, et al. Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring. Int J Immunopathol Pharmacol 2011; 24(2(S)): 121-8.
81. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nature Reviews Cancer 2005; 5(2): 127-35.
82. Mehrotra R, Singh MK, Pandya S, Singh M. The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2008; 106(2): 246-53.
83. Queiroz JB, Lima CF, Burim RA, Brandao AAH, Cabral LAG, Almeida JD. Exfoliative cytology of the oral mucosa: Comparison of two collection methods. General dentistry 2010; 58(5): e196-e9.
84. Navone R, Burlo P, Pich A, et al. The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. Cytopathology 2007; 18(6): 356-60.
85. Divani S, Exarhou M, Theodorou LN, Georgantzis D, Skoulakis H. Advantages and difficulties of brush cytology in the identification of early oral cancer. Archive of Oncology 2009; 17(1-2): 11-2.
86. Sudbø J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia (Retraction in: New England Journal of Medicine (2006) 355: 18 (1927)). New Eng J Med 2001; 344(17): 1270-8.
87. Poate TWJ, Buchanan JAG, Hodgson TA, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 2004; 40(8): 829-34.
88. Toyoshima T, Koch F, Kaemmerer P, Vairaktaris E, Al-Nawas B, Wagner W. Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: Preliminary results. J Oral Pathol Med 2009; 38(6): 530-4.
89. Acha A, Ruesga MT, Rodrìguez MJ, Martìnez De Pancorbo MA, Aguirre JM. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer 2005; 10(2): 95-102.
90. Remmerbach TW, Weidenbach H, Hemprich A, Böcking A. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: Report on four cases. Analytical Cellular Pathol 2003; 25(4): 159-66.
91. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 2004; 33(7): 398-404.
92. Zhang L, Rosin MP. Loss of heterozygosity: A potential tool in management of oral premalignant lesions? J Oral Pathol Med 2001; 30(9): 513-20.
93. Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specificity of the OralCDx technique: Evaluation of 103 cases. Oral Oncol 2004; 40(8): 824-8.
94. Hohlweg-Majert B, Deppe H, Metzger MC, et al. Sensitivity and specificity of oral brush biopsy. Cancer Investigation 2009; 27(3): 293-7.
95. Felefli S, Flaitz CM. The oral brush biopsy: it's as easy as 1, 2, 3. Texas dental J 2000; 117(6): 20-4.
96. Eisen D, Frist S. Efficacy of the brush biopsy [1]. J Oral Maxillofacial Surgery 2003; 61(10): 1237.
97. Kara MA, Ennahachi M, Fockens P, ten Kate FJW, Bergman JJGHM. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointestinal Endoscopy 2006; 64(2): 155-66.
98. Muto M, Minashi K, Yano T, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: A multicenter randomized controlled trial. J Clinical Oncol 2010; 28(9): 1566-72.
99. Yang SW, Lee YS, Chang LC, Hwang CC, Luo CM, Chen TA. Use of endoscopy with narrow-band imaging system in evaluating oral leukoplakia. Head and Neck 2011.
100. Muto M, Katada C, Sano Y, Yoshida S. Narrow band imaging: A new diagnostic approach to visualize angiogenesis in superficial neoplasia. Clinical Gastroenterology and Hepatology 2005; 3(7 SUPPL.): S16-S20.
101. Gono K, Yamazaki K, Doguchi N, et al. Endoscopic Observation of Tissue by Narrowband Illumination. Optical Rev 2003; 10(4): 211-5.
102. Ugumori T, Muto M, Hayashi R, Hayashi T, Kishimoto S. Prospective study of early detection of pharyngeal superficial carcinoma with the narrowband Imaging laryngoscope. Head and Neck 2009; 31(2): 189-94.
103. Katada C, Nakayama M, Tanabe S, et al. Narrow band imaging for detecting superficial oral squamous cell carcinoma: A report of two cases. Laryngoscope 2007; 117(9): 1596-9.
104. Tan NCW, Mellor T, Brennan PA, Puxeddu R. Use of narrow band imaging guidance in the management of oral erythroplakia. Br J Oral Maxillofacial Surgery 2011; 49(6): 488-90.
105. Chu PY, Tsai TL, Tai SK, Chang SY. Effectiveness of narrow band imaging in patients with oral squamous cell carcinoma after treatment. Head and Neck 2011.
106. Sankaranarayanan R, Ramadas K, Thomas G, et al. Trivandrum Oral Cancer Screening Group. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005; 365(9475): 1927-1933.
107. Paderni C, Compilato D, Carinci F, et al. Direct visualization of oral cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring. Int J Immunopathol Pharmacol 2011; 24: 201-10.